# FDA Inspection 1175240 - EMS Acquisition Corp - July 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/ems-acquisition-corp/82058e4b-8b13-486e-b5a2-bd1119647ad2
Source feed: FDA_Inspections

> FDA Inspection 1175240 for EMS Acquisition Corp on July 22, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1175240
- Company Name: EMS Acquisition Corp
- Inspection Date: 2022-07-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1280192 - 2025-10-24](https://www.keypedia.com/records/fda_inspections/ems-acquisition-corp/81e29acc-4c35-40a0-84fc-68eef2646efd)
- [FDA Inspection 947578 - 2015-10-22](https://www.keypedia.com/records/fda_inspections/ems-acquisition-corp/6eb5ef7d-cdc6-4d68-9a46-75a4114676c3)
- [FDA Inspection 815025 - 2013-01-10](https://www.keypedia.com/records/fda_inspections/ems-acquisition-corp/44f4ebdd-712e-4475-bdde-a20b85f1f98c)
- [FDA Inspection 546322 - 2008-11-06](https://www.keypedia.com/records/fda_inspections/ems-acquisition-corp/38403121-75bc-4ca4-9d7a-28f3b085eae0)

Company: https://www.keypedia.com/companies/ems-acquisition-corp/cee4bc8f-ba39-4d0e-a1b7-afe5724ced65

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c